TMEM39B
gene geneOn this page
Also known as FLJ10315
Summary
TMEM39B (transmembrane protein 39B, HGNC:25510) is a protein-coding gene on chromosome 1p35.2, encoding Transmembrane protein 39B (Q9GZU3). May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase.
Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in membrane.
Source: NCBI Gene 55116 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_018056
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25510 |
| Approved symbol | TMEM39B |
| Name | transmembrane protein 39B |
| Location | 1p35.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10315 |
| Ensembl gene | ENSG00000121775 |
| Ensembl biotype | protein_coding |
| Entrez | 55116 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 8 protein_coding, 6 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000336294, ENST00000438825, ENST00000441402, ENST00000466321, ENST00000468135, ENST00000472503, ENST00000476968, ENST00000487305, ENST00000498613, ENST00000862064, ENST00000862065, ENST00000933549, ENST00000933550, ENST00000969125, ENST00000969126
RefSeq mRNA: 4 — MANE Select: NM_018056
NM_001319677, NM_001319678, NM_001319679, NM_018056
CCDS: CCDS351
Canonical transcript exons
ENST00000336294 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001612773 | 32072939 | 32073051 |
| ENSE00001696754 | 32102431 | 32102863 |
| ENSE00003463525 | 32100442 | 32100562 |
| ENSE00003547709 | 32074951 | 32075077 |
| ENSE00003599151 | 32075603 | 32075822 |
| ENSE00003621741 | 32091675 | 32092011 |
| ENSE00003634453 | 32076763 | 32076846 |
| ENSE00003640931 | 32077164 | 32077318 |
| ENSE00003690523 | 32094784 | 32094971 |
Expression profiles
Bgee: expression breadth ubiquitous, 219 present calls, max score 88.59.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 25.3733 / max 190.6538, expressed in 1808 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1939 | 23.7603 | 1808 |
| 1938 | 1.6129 | 922 |
Top tissues by expression
276 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.59 | gold quality |
| monocyte | CL:0000576 | 86.64 | gold quality |
| granulocyte | CL:0000094 | 86.53 | gold quality |
| mononuclear cell | CL:0000842 | 86.49 | gold quality |
| leukocyte | CL:0000738 | 86.43 | gold quality |
| cortical plate | UBERON:0005343 | 85.41 | gold quality |
| body of uterus | UBERON:0009853 | 84.95 | gold quality |
| ganglionic eminence | UBERON:0004023 | 84.79 | gold quality |
| stromal cell of endometrium | CL:0002255 | 84.74 | gold quality |
| endocervix | UBERON:0000458 | 84.62 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 84.46 | gold quality |
| ectocervix | UBERON:0012249 | 84.39 | gold quality |
| ventricular zone | UBERON:0003053 | 83.89 | gold quality |
| thoracic aorta | UBERON:0001515 | 83.77 | gold quality |
| ascending aorta | UBERON:0001496 | 83.76 | gold quality |
| right ovary | UBERON:0002118 | 83.70 | gold quality |
| right coronary artery | UBERON:0001625 | 83.03 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 82.88 | gold quality |
| apex of heart | UBERON:0002098 | 82.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.84 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 82.66 | gold quality |
| left ovary | UBERON:0002119 | 82.57 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 82.49 | gold quality |
| aorta | UBERON:0000947 | 82.34 | gold quality |
| right lobe of liver | UBERON:0001114 | 82.16 | gold quality |
| left coronary artery | UBERON:0001626 | 82.16 | gold quality |
| left uterine tube | UBERON:0001303 | 81.82 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.81 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 81.67 | gold quality |
| adenohypophysis | UBERON:0002196 | 81.67 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.79 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
14 targeting TMEM39B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4425 | 100.00 | 67.59 | 1049 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-1290 | 99.59 | 69.90 | 2079 |
| HSA-MIR-887-5P | 98.82 | 65.90 | 1347 |
| HSA-MIR-4275 | 97.96 | 68.42 | 1549 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-3165 | 96.18 | 66.22 | 473 |
| HSA-MIR-3117-3P | 95.96 | 67.82 | 473 |
| HSA-MIR-8083 | 95.93 | 67.55 | 694 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem39b | ENSDARG00000018956 |
| mus_musculus | Tmem39b | ENSMUSG00000053730 |
| rattus_norvegicus | Tmem39b | ENSRNOG00000023746 |
| drosophila_melanogaster | CG13016 | FBGN0033899 |
| caenorhabditis_elegans | tmem-39 | WBGENE00017003 |
Paralogs (1): TMEM39A (ENSG00000176142)
Protein
Protein identifiers
Transmembrane protein 39B — Q9GZU3 (reviewed: Q9GZU3)
All UniProt accessions (3): Q9GZU3, F8WB89, Q5VVU5
UniProt curated annotations — full annotation on UniProt →
Function. May protect the cells against DNA damage caused by exposure to the cold-warming stress and facilitates tissue damage repair during the recovery phase.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the TMEM39 family.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9GZU3-1 | 1 | yes |
| Q9GZU3-2 | 2 | |
| Q9GZU3-3 | 3 | |
| Q9GZU3-4 | 4 |
RefSeq proteins (4): NP_001306606, NP_001306607, NP_001306608, NP_060526* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019397 | Uncharacterised_TMEM39 | Family |
Pfam: PF10271
UniProt features (19 total): transmembrane region 8, splice variant 6, chain 1, compositionally biased region 1, glycosylation site 1, sequence conflict 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9GZU3-F1 | 74.45 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 8
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 80 (showing top):
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, FISCHER_DREAM_TARGETS, CTTTGTA_MIR524, DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP, SENESE_HDAC3_TARGETS_DN, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, chr1p35, GOCC_ORGANELLE_SUBCOMPARTMENT, GCM_DENR, BARX1_TARGET_GENES, FOXN3_TARGET_GENES, HOXB4_TARGET_GENES, HOXC6_TARGET_GENES, RBM34_TARGET_GENES, SETD7_TARGET_GENES
GO Biological Process (1): biological_process (GO:0008150)
GO Molecular Function (0):
GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), endoplasmic reticulum (GO:0005783)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| endomembrane system | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
488 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM39B | SIRAL2 | Q9NWS6 | 522 |
| TMEM39B | REEP6 | Q96HR9 | 428 |
| TMEM39B | DNAJC18 | Q9H819 | 415 |
| TMEM39B | GPR137C | Q8N3F9 | 402 |
| TMEM39B | LETM2 | Q2VYF4 | 399 |
| TMEM39B | RHBDD3 | Q9Y3P4 | 392 |
| TMEM39B | GSG1 | Q2KHT4 | 392 |
| TMEM39B | TCP11L2 | Q8N4U5 | 376 |
| TMEM39B | MED19 | A0JLT2 | 371 |
| TMEM39B | PLD6 | Q8N2A8 | 370 |
| TMEM39B | ASXL3 | Q9C0F0 | 360 |
| TMEM39B | METTL26 | Q96S19 | 360 |
| TMEM39B | UBA5 | Q9GZZ9 | 360 |
| TMEM39B | STARD9 | Q9P2P6 | 359 |
| TMEM39B | PAQR3 | Q6TCH7 | 353 |
IntAct
54 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| LRFN4 | RIMOC1 | psi-mi:“MI:0914”(association) | 0.530 |
| SEMA7A | SGPL1 | psi-mi:“MI:0914”(association) | 0.530 |
| SCN3B | ABCC5 | psi-mi:“MI:0914”(association) | 0.530 |
| ADAM33 | LRP5 | psi-mi:“MI:0914”(association) | 0.530 |
| UBXN8 | psi-mi:“MI:0914”(association) | 0.530 | |
| PBXIP1 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| ISLR | BCKDK | psi-mi:“MI:0914”(association) | 0.530 |
| B4GAT1 | ADCY6 | psi-mi:“MI:0914”(association) | 0.530 |
| CHRNA4 | FZD6 | psi-mi:“MI:0914”(association) | 0.530 |
| KCNA2 | FADS1 | psi-mi:“MI:0914”(association) | 0.530 |
| LDLRAD1 | ADAM10 | psi-mi:“MI:0914”(association) | 0.530 |
| IL13RA1 | TMEM39B | psi-mi:“MI:0915”(physical association) | 0.370 |
| CHRNA9 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| ISLR | DDX11L8 | psi-mi:“MI:0914”(association) | 0.350 |
| NRG1 | HS6ST1 | psi-mi:“MI:0914”(association) | 0.350 |
| B4GAT1 | ADCY6 | psi-mi:“MI:0914”(association) | 0.350 |
| PMEL | MAN1A2 | psi-mi:“MI:0914”(association) | 0.350 |
| KCNA2 | TMEM129 | psi-mi:“MI:0914”(association) | 0.350 |
| TTYH1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| TSPAN15 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNA4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| CRELD1 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| LDLRAD1 | GXYLT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CMTM5 | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| HCST | TMEM120B | psi-mi:“MI:0914”(association) | 0.350 |
| CHRNB2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (51): TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS), TMEM39B (Affinity Capture-MS)
ESM2 similar proteins: A2BD92, A4FV45, A5D7N3, A7S641, B0BN86, D3Z2R5, F1Q930, O76024, O95870, P17152, P97587, Q0IJ20, Q17QW2, Q1JPD2, Q1JPG0, Q2HJ63, Q3B8H3, Q4QQM5, Q5BK13, Q5BLE2, Q5RAS8, Q5RJQ8, Q5SWK7, Q5SYH2, Q5ZLD4, Q66H44, Q6DC66, Q6DF19, Q6GR21, Q6MG55, Q6NRI4, Q6NUQ4, Q6NWH5, Q6ZQE4, Q7L4E1, Q7SZC5, Q7ZW11, Q7ZWF4, Q7ZYA0, Q810L4
Diamond homologs: Q0IHF1, Q0VCF5, Q17QW2, Q5U2V9, Q66H44, Q6DF19, Q6GL42, Q6GNY8, Q6NRI4, Q6PH58, Q7ZW11, Q810L4, Q9CYC3, Q9GZU3, Q9NV64
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2738 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:32073029:A:T | donor_gain | 1.0000 |
| 1:32073047:GATGG:G | donor_gain | 1.0000 |
| 1:32075077:GGTAA:G | donor_loss | 1.0000 |
| 1:32075078:G:C | donor_loss | 1.0000 |
| 1:32075079:T:A | donor_loss | 1.0000 |
| 1:32076844:G:GT | donor_gain | 1.0000 |
| 1:32077319:G:GG | donor_gain | 1.0000 |
| 1:32091946:G:GT | donor_gain | 1.0000 |
| 1:32092012:G:A | donor_loss | 1.0000 |
| 1:32092012:G:GG | donor_gain | 1.0000 |
| 1:32092013:T:A | donor_loss | 1.0000 |
| 1:32094778:CCCCA:C | acceptor_loss | 1.0000 |
| 1:32094779:CCCA:C | acceptor_loss | 1.0000 |
| 1:32094781:CAGA:C | acceptor_loss | 1.0000 |
| 1:32094782:A:AG | acceptor_gain | 1.0000 |
| 1:32094782:A:G | acceptor_loss | 1.0000 |
| 1:32094783:G:GG | acceptor_gain | 1.0000 |
| 1:32094783:GA:G | acceptor_gain | 1.0000 |
| 1:32094783:GAA:G | acceptor_gain | 1.0000 |
| 1:32094783:GAAC:G | acceptor_gain | 1.0000 |
| 1:32094783:GAACA:G | acceptor_gain | 1.0000 |
| 1:32094969:CCC:C | donor_gain | 1.0000 |
| 1:32094972:G:GG | donor_gain | 1.0000 |
| 1:32100558:TCCAT:T | donor_gain | 1.0000 |
| 1:32100559:CCATG:C | donor_loss | 1.0000 |
| 1:32100560:CAT:C | donor_gain | 1.0000 |
| 1:32100560:CATG:C | donor_loss | 1.0000 |
| 1:32100561:AT:A | donor_gain | 1.0000 |
| 1:32100562:TG:T | donor_loss | 1.0000 |
| 1:32100563:G:GC | donor_loss | 1.0000 |
AlphaMissense
3216 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:32091917:T:C | L278P | 1.000 |
| 1:32094908:C:A | A351D | 1.000 |
| 1:32094917:T:C | L354P | 1.000 |
| 1:32094919:G:C | G355R | 1.000 |
| 1:32094920:G:A | G355D | 1.000 |
| 1:32094920:G:T | G355V | 1.000 |
| 1:32094925:T:A | W357R | 1.000 |
| 1:32094925:T:C | W357R | 1.000 |
| 1:32094926:G:C | W357S | 1.000 |
| 1:32094927:G:C | W357C | 1.000 |
| 1:32094927:G:T | W357C | 1.000 |
| 1:32100443:T:A | W373R | 1.000 |
| 1:32100443:T:C | W373R | 1.000 |
| 1:32100445:G:C | W373C | 1.000 |
| 1:32100445:G:T | W373C | 1.000 |
| 1:32100461:T:A | W379R | 1.000 |
| 1:32100461:T:C | W379R | 1.000 |
| 1:32100463:G:C | W379C | 1.000 |
| 1:32100463:G:T | W379C | 1.000 |
| 1:32100500:T:G | Y392D | 1.000 |
| 1:32100528:C:A | A401D | 1.000 |
| 1:32100533:C:A | P403T | 1.000 |
| 1:32100533:C:T | P403S | 1.000 |
| 1:32100534:C:A | P403H | 1.000 |
| 1:32100534:C:G | P403R | 1.000 |
| 1:32100558:T:C | F411S | 1.000 |
| 1:32091898:C:A | R272S | 0.999 |
| 1:32091899:G:C | R272P | 0.999 |
| 1:32091905:A:T | E274V | 0.999 |
| 1:32091928:T:C | F282L | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000041923 (1:32100347 G>A,T), RS1000075197 (1:32096747 C>T), RS1000297876 (1:32090494 C>T), RS1000314157 (1:32078445 T>C), RS1000530257 (1:32085478 C>T), RS1000566352 (1:32082975 C>A,T), RS1000601793 (1:32083982 T>G), RS1000625410 (1:32077048 G>A), RS1000626273 (1:32083991 A>C), RS1000630444 (1:32091495 C>T), RS1000825767 (1:32071319 G>A,C), RS1000890109 (1:32072907 C>T), RS1000892643 (1:32088432 A>G), RS1000932129 (1:32073820 A>G), RS1001029615 (1:32088769 C>CT,CTTTTTTTTTTTTTTTTTTTTTTT,CTTTTTTTTTTTTTTTTTTTTTTTT)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_36 | Body mass index | 9.000000e-10 |
| GCST012038_1 | Sleep duration (> 10 hours) | 3.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, decreases expression | 3 |
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| bufotalin | decreases expression | 1 |
| beta-lapachone | decreases expression, increases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Vorinostat | decreases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Asbestos, Crocidolite | increases methylation | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B5L3 | HAP1 TMEM39B (-) 2 | Cancer cell line | Male |
| CVCL_XU52 | HAP1 TMEM39B (-) 1 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.